Xtoro approved for swimmer's ear
(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.
Dec 18, 2014
0
0
(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.
Dec 18, 2014
0
0
It's unthinkable to give a placebo to someone to treat their cancer, but could we use one to treat chemotherapy's well-known side effects? Unfortunately, we may never be able to answer this question because the biggest obstacle ...
Nov 10, 2014
0
0
(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...
Oct 11, 2014
0
0
Meclizine, an over-the-counter drug used for decades to treat nausea and motion sickness, has the potential for new uses to treat certain infectious diseases and some forms of cancer, according to Dr. Vishal M. Gohil, Texas ...
Oct 30, 2013
0
0
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, ...
Oct 15, 2013
0
0
The potential use of propofol in a Missouri execution next month is raising concerns that the anti-death penalty European Union could limit its export, endangering the supply of the vital anesthetic to thousands of hospitals ...
Sep 27, 2013
2
0
(HealthDay)—Dual continuous epidural analgesia (CEA) is the most effective pain control method following surgery for adolescent idiopathic scoliosis, according to a study published in the Sept. 1 issue of Spine.
Sep 18, 2013
0
0
(HealthDay)—In patients undergoing reconstructive spine surgery, combined epidural and general anesthesia results in better pain control and other outcomes compared with general anesthesia plus narcotics, according to a ...
Jul 17, 2013
0
0
(HealthDay)—Brisdelle (paroxetine) has been approved by the U.S. Food and Drug Administration as the first non-hormonal treatment to treat hot flashes associated with menopause.
Jul 1, 2013
0
0
(HealthDay)—Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.
Jun 13, 2013
0
0